Efficacy of VIA, VILI, PAP Smear, and FRD Tests in Screening for Cervical Cancer: A Comparative Study
- 4 October 2021
- journal article
- research article
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 19 (4) , 1-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cervical Cancer ScreeningObstetrics & Gynecology, 2016
- When and how often to screen for cervical cancer in three low- and middle-income countries: A cost-effectiveness analysisPapillomavirus Research, 2015
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- HPV-based screening for prevention of invasive cervical cancerThe Lancet, 2014
- Cervical cancer screening: on the way to a shift from cytology to full molecular screeningAnnals of Oncology, 2014
- Global burden of cancers attributable to infections in 2008: a review and synthetic analysisThe Lancet Oncology, 2012
- Accuracy of visual inspection with acetic acid for cervical cancer screeningInternational Journal of Gynecology & Obstetrics, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Folate Receptor-Mediated Drug Targeting: From Therapeutics to DiagnosticsJournal of Pharmaceutical Sciences, 2005
- Methylene blue–directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagusGastrointestinal Endoscopy, 2000